Robert Alexander Ingram, Director at REGENERON PHARMACEUTICALS INC (REGN), sold 5,167 shares at $513.39 ($2.7M) on 2015-05-27, disclosed to the SEC on 2015-05-27.
Open-market sale of $2.7M REGN by Director. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Nothing distinguishes this filing.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $516.48 | 3,788 | $2.0M | 73.4% |
| 2 | $513.39 | 1,379 | $708K | 26.6% |
| Total | $515.66 avg | 5,167 | $2.7M | 100% |
| Filing → |
| NOVN | BUY | 2019-05-23 | $111K | — | Filing → |
| NOVN | BUY | 2018-10-01 | $142K | — | Filing → |
| NOVN | BUY | 2017-08-29 | $55K | — | Filing → |